Skip to main content
. 2024 Jan 29;32(1):55–61. doi: 10.5606/tgkdc.dergisi.2024.25393

Table 4. Multivariate analysis results in terms of recurrence-free survival and overall survival.

  Recurrence free survival Overall survival
HR 95% CI p HR 95% CI p
Age 1.001 0.966-1.036 0.975 1.013 0.978-1.049 0.466
Sex 0.842 0.310-2.285 0.736 1.755 0.540-5.707 0.350
Tumor type (primary/secondary) 1.380 0.252-7562 0.711 3.055 0.299-31.204 0.346
Tumor pathology (carcinoma/sarcoma) 1.007 0.145-6.995 0.994 2.048 0.163-25.742 0.579
Grade 2.443 1.312-4.549 0.005 2.032 1.005-4.109 0.048
Stage 0.939 0.511-1.725 0.839 0.762 0.396-1.467 0.417
Resection margin 1.749 0.532-5.749 0.357 1.863 0.643-5.399 0.252
Rib resection 0.066 0.016-0.278 <0.001 0.128 0.029-0.566 0.007
Neoadjuvant treatment 1.308 0.503-3.404 0.582 1.044 0.387-2.812 0.932
Adjuvant treatment 2.737 0.530-14.135 0.229 1.997 0.405-9.838 0.395
HR: Hazard ratio; CI: Confidence interval.